|
|
JACKSON CENTER, PA / ACCESSWIRE / June 8, 2022 / Halberd Corporation OTC PINK:HALB and Mississippi State University MSU executed a nondisclosure agreement NDA to explore animal testing as the next step in obtaining FDA certification for Halberds patented extracorporeal disease eradication processes. Consistent with its press release of May 18, 2022, Halberd commenced its pursuits... Lire le communiqué |
|
| |
|
| |
|
|
JACKSON CENTER, PA / ACCESSWIRE / May 24, 2022 / Halberd Corporation OTC PINK:HALB researchers have demonstrated a protocol which allows for the precise level of elimination of a specific targeted cytokine from a homogeneous mixture of two different cytokines in a fluid. Several adverse health conditions are caused by excess quantities of particular components in blood or cerebral spinal fluid... Lire le communiqué |
|
| |
|
| |
|
|
JACKSON CENTER, PA / ACCESSWIRE / May 18, 2022 / Halberd Corporation OTC PINK:HALB has engaged the services of mdi Consultants, Inc. mdi to assist Halberd in navigating the U.S. Food and Drug Administrations FDA complex application and certification processes. mdi will guide Halberd on the FDA application and testing protocol and assist in filing the appropriate documents and disclosures with the... Lire le communiqué |
|
| |
|
| |
|
|
JACKSON CENTER, PA / ACCESSWIRE / May 12, 2022 / Halberd Corporation OTC PINK:HALB submitted its fully audited financials through its fiscal second quarter and Form10 to the SEC as its initial step to uplist from OTCPINK to OTCQB on the OTC Markets exchange. Once Halberds shares are qualified under the Securities Exchange Act of 1934 the "34 Act", Halberd will become a fully reporting... Lire le communiqué |
|
| |
|
| |
|
|
JACKSON CENTER, PA / ACCESSWIRE / April 29, 2022 / A key member of Halberd Corporations OTC PINK:HALB Research Team, Dr. W. Gregg Sturrus, recently gave a TEDx Talk® on Halberds patented and patentpending extracorporeal elimination of neurodegenerative disease proteins and cytokines using lasers and metallic nanoparticles. The video can be found here.... Lire le communiqué |
|
| |
|
| |
|
|
Q1 Accomplishments and Q2 PlansJACKSON CENTER, PA / ACCESSWIRE / April 25, 2022 /Greetings From The CEO And Staff At HALBERD CORPORATION! OTC PINK:HALBThis past quarter has witnessed some very significant technical and organizational achievements by the Halberd team.Q1 OVERVIEW AND ACHIEV... Lire le communiqué |
|
| |
|
| |
|
|
JACKSON CENTER, PA / ACCESSWIRE / April 18, 2022 / Halberd Corporation OTC PINK:HALB demonstrated the efficacy of its patented extracorporeal methodology for treatment and eradication of disease states. The latest success was again extracorporeal elimination of E. coli bacteria from cerebral spinal fluid CSF by exposure to tuned laser light, in vitro, in under 20 minutes. This compares to up to... Lire le communiqué |
|
| |
|
| |
